Literature DB >> 8008687

Histopathological findings in a male with late-onset ornithine transcarbamylase deficiency.

S Capistrano-Estrada1, D L Marsden, W L Nyhan, R O Newbury, H F Krous, M Tuchman.   

Abstract

Late onset of symptoms in a 12 1/2-year-old male with ornithine transcarbamylase (OTC) deficiency were associated with unusual histological features in the liver. The patient presented with an acute onset of hyperammonemia and altered mental status after a 2-day prodrome of vomiting and lethargy. Physical examination showed a combative and disoriented male with icteric sclerae but with no fever or hepatomegaly. The plasma ammonia level was 282 microM. Enzyme assays of liver tissue obtained by percutaneous needle biopsy showed OTC activity of approximately 3% of normal; carbamyl phosphate synthetase was normal. Histopathological findings included severe microvesicular centrilobular steatosis. Hepatic architecture and reticulin framework were well preserved. Many hepatocyte nuclei were filled with glycogen. Electron microscopy showed mitochondria that were rounded and expanded with cristae at the edge of the mitochondrial membrane. In contrast to other reports, only slight variations in size and shape were seen. Megamitochondria and intramatrical paracrystalline inclusions were not identified. The cytoplasm contained scattered fat globules, peroxisomes, and dilated smooth endoplasmic reticulum. The prominent mitochondrial abnormalities commonly found in OTC deficiency were notably absent.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8008687     DOI: 10.3109/15513819409024257

Source DB:  PubMed          Journal:  Pediatr Pathol        ISSN: 0277-0938


  4 in total

1.  Pitfalls in the detection of heterozygosity by allopurinol in a variant form of ornithine carbamoyltransferase deficiency.

Authors:  B A Barshop; W L Nyhan; C Climent; V Rubio
Journal:  J Inherit Metab Dis       Date:  2001-08       Impact factor: 4.982

2.  Hepatocellular carcinoma in a research subject with ornithine transcarbamylase deficiency.

Authors:  James M Wilson; Oleg A Shchelochkov; Renata C Gallagher; Mark L Batshaw
Journal:  Mol Genet Metab       Date:  2011-11-07       Impact factor: 4.797

3.  Significant hepatic involvement in patients with ornithine transcarbamylase deficiency.

Authors:  Renata C Gallagher; Christina Lam; Derek Wong; Stephen Cederbaum; Ronald J Sokol
Journal:  J Pediatr       Date:  2014-01-30       Impact factor: 4.406

4.  Ornithine transcarbamylase downregulation is associated with poor prognosis in hepatocellular carcinoma.

Authors:  Lin He; Xuefei Cai; Shengtao Cheng; Hongzhong Zhou; Zhenzhen Zhang; Jihua Ren; Fang Ren; Qiuxia Yang; Nana Tao; Juan Chen
Journal:  Oncol Lett       Date:  2019-03-21       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.